A certificate of analysis (COA) is a laboratory record for one identified batch of material. It should state what was tested, which methods were used, and what values were obtained, and it should name the laboratory that did the work. For research peptides, the two questions that matter first are identity (is this the intended molecule?) and chromatographic purity (how much of the detected material is that molecule?). A third question — how much peptide is present by mass — is separate again, and is not answered by a headline percentage.
This reading guide is for anyone in Australia assessing a peptide COA or looking for third-party tested peptides. It is reference information only. All Au Peptide Labs materials are supplied strictly for laboratory research use. They are not for human or veterinary use, and not for human consumption.
What a COA is — and what it is not
A complete certificate is evidence of testing, not a marketing page or a guarantee of fitness for any purpose. A glossy claim of “99% purity” with no method, no batch number and no named laboratory is a claim, not a certificate. The difference is whether the work can be checked.
A useful COA makes at least the following explicit: the compound identity, ideally with a sequence or other structural reference; a batch or lot number that can be matched to the vial; the manufacture date and the test date; the analytical methods used; the measured values, with units and against any stated specification; and the name of the testing laboratory, and a signature or named analyst. If a field is missing, that absence is itself information. A longer field-by-field walk-through is on aupeptidelabs.com.au/resources/reading-a-coa.
Batch numbers: the link between the vial and the document
A batch (or lot) number identifies a single production run. The certificate describes that run, and only that run. The first practical check is also the simplest: the number printed on the certificate should match the number on the vial in hand. If the two differ, the document does not describe that material.
One certificate should not be reused across several batches or vial sizes — a report covers the material that was actually tested. The test date should also fall after manufacture, and be recent enough to be meaningful for the work being planned. Au Peptide Labs publishes third-party certificates on aupeptidelabs.com.au/coas. Each published report is tied to a named compound and to the vial size that was tested.
HPLC purity: composition, not identity and not quantity
Most peptide purity figures come from reverse-phase high-performance liquid chromatography (HPLC). The dissolved sample is passed through a non-polar column. Components that interact differently with the column leave it at different times, and a detector records a chromatogram: signal against time.
The main peak is the tall, dominant peak — the intended compound under that method — and its retention time should be consistent with the stated conditions. A flat, quiet baseline between peaks makes small neighbouring peaks easier to judge. Impurity peaks are the smaller signals before and after the main peak; peaks that sit on the shoulder of the main peak are harder to quantify than well-separated ones. Chromatographic purity is usually the area of the main peak divided by the total area of all integrated peaks, expressed as a percentage. Because that figure depends on the method and the detector, a purity number without a stated method is incomplete.
International Council for Harmonisation guideline ICH Q2(R2) sets out the principles used to show that an analytical procedure is fit for its intended purpose. It treats identity, purity and impurity testing as distinct purposes, and it asks that a chromatographic procedure be shown to be specific, including that relevant peaks in a critical separation are adequately resolved (ICH Q2(R2)). That is why a certificate should name the method, not only quote a percentage.
HPLC does not, on its own, confirm chemical identity: a well-resolved main peak still has to be identified by an orthogonal method, typically mass spectrometry. It also does not report how much peptide is present by mass. Salt, residual water and any excipient add to the weight of a freeze-dried powder, and they are not what a peak-area percentage measures. The difference between chromatographic purity and net peptide content is explained on aupeptidelabs.com.au/resources/purity-vs-peptide-content. Method limits more generally are summarised on aupeptidelabs.com.au/resources/lab-testing-methods.
Mass spectrometry: identity by molecular mass
Mass spectrometry answers a different question. The sample is ionised, the ions are separated by their mass-to-charge ratio (m/z), and the instrument reports a molecular mass for the detected species. As Ho and colleagues describe in a methods review, mass spectrometry can provide both qualitative (structure) and quantitative (molecular mass) information once analyte molecules have been converted to ions and recorded as a mass spectrum of relative abundance against m/z (Ho et al., 2003).
On a peptide certificate, that measurement is compared with the theoretical mass calculated from the stated sequence. A match between the observed and expected molecular mass is strong evidence that the tested material is the intended compound. A mass match does not measure purity, and it does not measure how much peptide is in the vial. The intended molecule can still be present alongside impurities, residual solvent or counter-ion salt. Identity, purity and content are therefore three questions, and a certificate that speaks to only one of them is only partly informative.
Third-party testing, and how to check a report
“Third-party tested” should mean that an independent laboratory, with no commercial stake in the figure, performed the work and can be contacted. An in-house figure from the supplier is a weaker claim than a named, contactable laboratory that hosts its own copy of the report.
Match the batch number on the certificate to the number on the vial. Open the testing laboratory’s own record of the work, not only a copy hosted by the supplier, and compare the compound, the method and the measured values. Confirm that purity is supported by a stated chromatographic method, and that identity is supported by mass spectrometry. Check that the report covers the vial size in hand. Published Au Peptide Labs reports are on aupeptidelabs.com.au/coas.
Common gaps that weaken a certificate
Any one of the following should prompt more questions before the document is treated as evidence: no batch number, or a number that does not match the vial; no manufacture or test date; no named testing laboratory, or one that cannot be contacted independently; one certificate reused across multiple batches or sizes; a purity figure quoted without a method; or an image-only document with no chromatogram or mass-spectrometry data underneath it. A high percentage, on its own, never closes those gaps.
A research peptide COA is most useful when read as complementary measurements: batch traceability, HPLC for composition, mass spectrometry for identity, and, where reported, a separate content measurement. Third-party testing only adds confidence when that report can be checked at the issuing laboratory.
For laboratory research use only. Not for human or veterinary use.
References
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Harmonised Guideline Q2(R2): Validation of Analytical Procedures. Final version, adopted 1 November 2023 (error-correction edition, 2025). https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130_ErrorCorrection_2025.pdf
- Ho CS, Lam CWK, Chan MHM, Cheung RCK, Law LK, Lit LCW, Ng KF, Suen MWM, Tai HL. Electrospray ionisation mass spectrometry: principles and clinical applications. The Clinical Biochemist Reviews. 2003;24(1):3–12. https://pmc.ncbi.nlm.nih.gov/articles/PMC1853331/